Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Amortization of Deferred Charges (2019 - 2021)

Protagonist Therapeutics (PTGX) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $491000.0 as the latest value for Q3 2021.

  • Quarterly Amortization of Deferred Charges rose 10.59% to $491000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Sep 2021, up 2.59% year-over-year, with the annual reading at $1.8 million for FY2020, 0.95% down from the prior year.
  • Amortization of Deferred Charges hit $491000.0 in Q3 2021 for Protagonist Therapeutics, up from $443000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $491000.0 in Q3 2021 to a low of $443000.0 in Q2 2020.
  • Historically, Amortization of Deferred Charges has averaged $449545.5 across 3 years, with a median of $444000.0 in 2019.
  • Biggest five-year swings in Amortization of Deferred Charges: fell 3.27% in 2020 and later grew 10.59% in 2021.
  • Year by year, Amortization of Deferred Charges stood at $445000.0 in 2019, then fell by 0.22% to $444000.0 in 2020, then grew by 10.59% to $491000.0 in 2021.
  • Business Quant data shows Amortization of Deferred Charges for PTGX at $491000.0 in Q3 2021, $443000.0 in Q2 2021, and $444000.0 in Q1 2021.